By expenditures
| Name | Title | Type |
|---|---|---|
| Jillian Gonzalez | Executive Director | Auditee |
| Carmen Ziegler | Vice President & CFO | Auditee |
| Thure Ross | Signing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 397281 | 2025 | 2026-03-31 | CLIFTONLARSONALLEN LLP | $16.76M |
| 341153 | 2024 | 2025-02-04 | Cliftonlarsonallen LLP | $16.02M |
| 292608 | 2023 | 2024-02-28 | Cliftonlarsonallen LLP | $15.02M |
| 26578 | 2022 | 2023-02-05 | Cliftonlarsonallen LLP | $14.49M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 397281 | 2025 | 2026-03-31 | 1205597 | 2025-002 | Material Weakness | Yes | L |
| 397281 | 2025 | 2026-03-31 | 1205596 | 2025-002 | Material Weakness | Yes | L |
| 397281 | 2025 | 2026-03-31 | 1205595 | 2025-002 | Material Weakness | Yes | L |
| 397281 | 2025 | 2026-03-31 | 1205594 | 2025-002 | Material Weakness | Yes | L |
| 397281 | 2025 | 2026-03-31 | 1205593 | 2025-002 | Material Weakness | Yes | L |
| 397281 | 2025 | 2026-03-31 | 1205592 | 2025-002 | Material Weakness | Yes | L |
| 397281 | 2025 | 2026-03-31 | 1205591 | 2025-002 | Material Weakness | Yes | L |
| 397281 | 2025 | 2026-03-31 | 1205590 | 2025-002 | Material Weakness | Yes | L |
| 397281 | 2025 | 2026-03-31 | 1205589 | 2025-002 | Material Weakness | Yes | L |
| 397281 | 2025 | 2026-03-31 | 1205588 | 2025-002 | Material Weakness | Yes | L |
| 397281 | 2025 | 2026-03-31 | 1205587 | 2025-001 | Material Weakness | Yes | B |
| 397281 | 2025 | 2026-03-31 | 1205586 | 2025-001 | Material Weakness | Yes | B |
| 397281 | 2025 | 2026-03-31 | 1205585 | 2025-001 | Material Weakness | Yes | B |
| 397281 | 2025 | 2026-03-31 | 1205584 | 2025-001 | Material Weakness | Yes | B |
| 397281 | 2025 | 2026-03-31 | 1205583 | 2025-001 | Material Weakness | Yes | B |
| 397281 | 2025 | 2026-03-31 | 1205582 | 2025-001 | Material Weakness | Yes | B |
| 397281 | 2025 | 2026-03-31 | 1205581 | 2025-001 | Material Weakness | Yes | B |
| 397281 | 2025 | 2026-03-31 | 1205580 | 2025-001 | Material Weakness | Yes | B |
| 397281 | 2025 | 2026-03-31 | 1205579 | 2025-001 | Material Weakness | Yes | B |
| 397281 | 2025 | 2026-03-31 | 1205578 | 2025-001 | Material Weakness | Yes | B |
| 292608 | 2023 | 2024-02-28 | 947429 | 2023-001 | Significant Deficiency | - | AB |
| 292608 | 2023 | 2024-02-28 | 947428 | 2023-001 | Significant Deficiency | - | AB |
| 292608 | 2023 | 2024-02-28 | 370987 | 2023-001 | Significant Deficiency | - | AB |
| 292608 | 2023 | 2024-02-28 | 370986 | 2023-001 | Significant Deficiency | - | AB |
| 26578 | 2022 | 2023-02-05 | 607552 | 2022-001 | Significant Deficiency | - | L |
| 26578 | 2022 | 2023-02-05 | 607551 | 2022-001 | Significant Deficiency | - | L |
| 26578 | 2022 | 2023-02-05 | 31110 | 2022-001 | Significant Deficiency | - | L |
| 26578 | 2022 | 2023-02-05 | 31109 | 2022-001 | Significant Deficiency | - | L |